Wednesday, February 10, 2010, 7:50pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Cambrex Corp. (CBM)

At 5:02AM SGT: 5.27 USD   0.00 (0.00%)  
 MORE ON CBM 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 CAMBREX CP (NYSE:CBM) Delayed quote dataEdit
Last Trade:5.27 USD
Trade Time:5:02AM SGT
Change: 0.00 (0.00%)
Prev Close:5.27
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:11.00
Day's Range:N/A - N/A
52wk Range:1.48 - 7.22
Volume:0
Avg Vol (3m):102,471
Market Cap:154.33M
P/E (ttm):12.64
EPS (ttm):0.42
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add CBM to Portfolio   Download Data

 HEADLINES 
•CAMBREX CORP Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Feb 6)
•Cambrex To Announce Fourth Quarter 2009 Financial Results On February 10, 2010
PR Newswire (Thu, Feb 4)
•Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
PR Newswire (Tue, Jan 5)
•CAMBREX CORP Financials
EDGAR Online Financials (Sat, Nov 7)
•CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Thu, Nov 5)
•Cambrex Earnings Call scheduled for 8:30 am ET today
CCBN (Wed, Nov 4)
•CAMBREX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Tue, Aug 25)
•CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, Aug 5)
•CAMBREX CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran
EDGAR Online (Fri, Jun 5)
•CAMBREX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
EDGAR Online (Wed, May 6)
More Headlines for CBM...
 ANALYST 
EPS Est (next year) (Dec-09) :0.50
EPS Est (in 2 years) (Dec-10) :0.56
Avg Rec (current)*:3.0
PEG Ratio:0.79
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Cambrex Corporation, a life sciences company, provides products and services to develop and commercialize active pharmaceutical ingredients and advanced intermediates.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices